Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients

Bonora, S.; Calcagno, A.; Vigano, O.; Bigliano, P.; Marinaro, L.; Colella, E.; Orofino, G.; Trentini, L.; Tettoni, M. C.; D'Avolio, A.; D?Avolio, A.; Mercadante, S.; Galli, M.; Di Perri, G.; Perri, G.; Rusconi, S.

Published in

Bentham Science Publishers, Current HIV Research: HIV and Viral Immune Diseases, 5(12), p. 339-346

DOI: 10.2174/1570162x12666140807151616

Tools

Export citation

Search in Google Scholar

Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients

Journal article published in 2014 by S. Bonora, A. Calcagno, O. Vigano, P. Bigliano, L. Marinaro, E. Colella, G. Orofino, L. Trentini, M. C. Tettoni, A. D'Avolio, A. D?Avolio, S. Mercadante, M. Galli, G. Di Perri, G. Perri and other authors.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients